Ionis Pharmaceuticals Insider Sold Shares Worth $1,744,623, According to a Recent SEC Filing

C Frank Bennett, Executive Vice President, Chief Scientific Officer, on July 07, 2026, sold 20,536 shares in Ionis Pharmaceuticals (IONS) for $1,744,623. Following the Form 4 filing with the SEC, Bennett has control over a total of 75,018 common shares of the company, with 75,018 shares held directly. SEC Filing: